Please login to the form below

Not currently logged in
Email:
Password:

Phillip Frost to remain chair of Teva Pharmaceutical

Re-elected by board for at least three more years

Phillip Frost - Teva PharmaceuticalDr Phillip Frost has been re-elected as chair of Teva Pharmaceutical.

The Israel-based firm's board of directors unanimously voted for Dr Frost to remain in the position for at least three more years, subject to shareholder approval.

He has served as chair since March 2010, having previously been vice chair from January 2006.

Prior to his time at Teva, he was chair and CEO of IVAX Xorporate from 1987 to 2006.

The board's vice chair, Professor Moshe Many, said: “Dr Phillip Frost has the Board's full support. We would continue to benefit from his vision and guidance.

“We look forward to the progress of the company under the governance of the Board and the leadership of Teva's President and CEO Dr. Jeremy Levin.”

Dr Frost's continuation provides Teva with some stability as former senior vice president of strategy at Bristol-Myers Squibb, Jeremy Levin, begins his tenure as the company's CEO and president.

The company has also recently appointed genetics expert Dr Michael Hayden as its first president of global R&D and chief scientific officer.

21st May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics